Skip to main content
Blizard Institute - Faculty of Medicine and Dentistry
  1. Blizard Institute
  2. All Staff
  3. Profiles

Professor Silvia Marino, MD, FRCPath

Silvia

Professor of Neuropathology

Centre: Centre for Genomics for Child Health

Email: s.marino@qmul.ac.uk
Telephone: +44 (0)20 7882 2585

Profile

Silvia Marino is the Director of the Brain Tumour Research Centre of Excellence, a partnership between QMUL and the charity Brain Tumour Research.

The focus of the Marino research group is on the biology of stem cells and progenitor cells, on the pathways and genes involved in control of their maintenance, proliferation and differentiation, in particular the Polycomb group genes. The group is currently investigating the role of deregulated epigenetic mechanisms in initiation and progression of brain tumours –medulloblastomas and glioblastomas- in experimental models and in human tumour samples.

Prof Marino is the lead of the Barts Brain Tumour Centre, a clinical research platform at QMUL/Barts Health funded by Barts Charity to take basic science discoveries to the clinic more effectively with the aim of increasing the availability of experimental treatments to brain tumour patients. 

In her clinical role as a consultant neuropathologist, she specialises in the neuropathological assessment of neuro-oncological surgical specimen and muscle biopsies.

Prof Marino is the current Vice-President of the British Neuropathology Society (BNS), the Academic Training Programme Director for Pathology at NHS England London and a past President of the British Neuro-Oncology Society (BNOS).

Summary

Silvia Marino is Professor of Neuropathology at Barts and The London School of Medicine and Dentistry, Queen Mary University of London and also Honorary Consultant Neuropathologist at Barts Health NHS Trust. After studying Medicine at the University of Turin in Italy, Professor Marino trained in Neuropathology and Histopathology at the University of Zurich in Switzerland. She trained in molecular genetics with Professor Anton Berns at The Netherlands Cancer Institute in Amsterdam as a Marie Curie Postdoctoral Fellow of the European Community studying the role of the tumour suppressor Rb and p53 in the pathogenesis of medulloblastoma in genetically engineered mouse models. She established her own laboratory research group in 2002 firstly at the Institute of Pathology, University of Zurich and then since 2006 at the Blizard Institute in London.

 
 
Group Members
Back to top